Characterizing T-cell responses to arbovirus infections using ELISpot tests
Official title: ARBOspot: Characterization of Arbovirus Specific T Cell Response in Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07291206 · Data updated 2026-11-12
This project will test whether ELISpot blood assays can detect T-cell immune responses in adults with suspected arbovirus infections.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia Academic / other |
| Locations | 1 site (Pavia, Lombardy) |
| Status | Recruiting |
| Started | May 17, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | March 4, 2026 |
| Trial ID | NCT07291206 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older of any sex with a suspected arbovirus infection who can give written informed consent are ideal candidates.
✕Probably not a fit
People without a current suspected arbovirus infection or those with conditions that would compromise safety or interfere with immune testing are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will enroll adults with suspected arbovirus infection at Fondazione IRCCS Policlinico San Matteo in Pavia and collect blood samples for immunological analysis. Researchers will use ELISpot and related assays to measure virus-specific T-cell responses and compare results with serology and clinical information. The work will include endemic and imported arboviruses such as WNV, TOSV, SFSV, SFNV, USUV, TBEV, CHIKV, DENV, ZIKV, YFV, and JEV. Results aim to map cellular immune profiles that could inform diagnosis and surveillance strategies.
Why it matters
Potential benefit: If successful, this could improve understanding of protective immune responses and help refine diagnostic and surveillance tools for arbovirus infections.
How similar studies have gone: ELISpot and similar T-cell assays have been used successfully to detect cellular immune responses in other viral infections and in some arbovirus research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults 18 years- old and over; all sexes will be eligible for the study; * Suspected arbovirus infection * Written informed consent and any required authorization obtained from the participant prior to performing any protocol-related procedures; Exclusion Criteria: * Any condition that might compromise safety or interfere with study results. * All other conditions not present in the inclusion criteria.
Where it's running
-
Fondazione IRCCS Policlinico San Matteo
Pavia, Lombardy, Italy Recruiting
Study contacts
- Study coordinator: Baldanti
- Email: segreteria.virologia@smatteo.pv.it
- Phone: +390382502420
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tracking mosquito-borne and other emerging virus infections in Fiji
This project will follow people aged 6 and older who live in Fiji's Central Division to see how often mosquito-borne and respiratory viruses infect them over time.
-
AirGo Respiratory Monitoring During Lung Resection
Patients undergoing lung resection will wear the AirGo device to continuously monitor breathing before and after surgery to see if it helps track ventilation alongside standard checks.
-
Experiences After Risk-Reducing Mastectomy in BRCA1/2 Carriers
This study asks women with BRCA1/2 or related variants who had risk-reducing mastectomy to share their experiences and satisfaction to see what factors are connected to how happy they are with the outcome.
-
Natural history of eosinophilic esophagitis in adults and children
This observational study tests how eosinophilic esophagitis progresses over time in people 5 years and older to understand symptoms and outcomes.
-
COVID-19 Registry at San Matteo (SMACORE) - patient-matching observational registry
This registry tests how COVID-19 patients are being treated and progress across San Matteo in Pavia to understand patterns and outcomes.
-
Registry of Transcatheter Aortic Valve Treatments at a Italian Center
This registry tests how safe and effective transcatheter valve procedures are in adults with severe aortic stenosis treated at a single Italian center.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.